PTC Therapeutics, Inc. (PTCT) Free cash flow 2016–2025
PTC Therapeutics, Inc. (PTCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$702.3MFY2025 · since FY2016: -$105.3M → $702.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $702.3M | +715.1% |
| FY2024 | -$114.2M | +38.9% |
| FY2023 | -$186.9M | +51.9% |
| FY2022 | -$388.7M | -39.0% |
| FY2021 | -$279.5M | -31.9% |
| FY2020 | -$211.9M | -88.5% |
| FY2019 | -$112.4M | -223.6% |
| FY2018 | -$34.7M | -163.9% |
| FY2017 | -$13.2M | +87.5% |
| FY2016 | -$105.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTCT financial trends
PTCT RevenuePTCT Net incomePTCT Net marginPTCT Gross profitPTCT Gross marginPTCT Operating incomePTCT Operating marginPTCT Operating cash flowPTCT Capital expendituresPTCT Return on equityPTCT Stock buybacksPTCT Dividends paidPTCT Total assetsPTCT Total liabilitiesPTCT Shareholders’ equityPTCT overview →